Position: Associate Director to Director, Biostatistics
Department: Global Medical-Biometrics and Quantitative Sciences
Location: Remote (PST Zone) with up to 20% global and domestic travel
Reports To: Executive Director, Biometrics
Position Summary
This position will report to the Executive Director of Biometrics and will provide statistical leadership across programs and trials from early- to late-phase development. The role will contribute strategically to project decisions and study operations, apply innovative statistical approaches (e.g., modeling and simulation, adaptive design, Bayesian methods), support and defend analyses and interpretations in internal cross-functional meetings, and prepare and communicate responses to regulatory agency inquiries.
Responsibilities
Qualifications
Requirements
Salary Range: $160,000 - $230,000
About Angitia
Established in June 2018, Angitia Biopharmaceuticals is a clinical-stage biotechnology company focused on the discovery and development of innovative therapeutics for serious musculoskeletal diseases. Angitia is currently studying 3 biologic product candidates in the clinic for the treatment of osteoporosis (Phase 2), osteogenesis imperfecta (OI) (Phase 1), and spinal fusion (Phase 3). Leveraging the team's extensive experience and scientific acumen in novel drug development, Angitia is committed to providing groundbreaking therapies to satisfy key unmet medical needs. The founder and the core team members of Angitia are seasoned scientific leaders in new drug discovery, development, and management from both overseas and domestic large multinational companies. The company has built an organization with offices in Westlake Village, CA and Guangzhou, China that is distinguished by world-class scientists with talents that are proficient in the pathophysiology of musculoskeletal diseases. We utilize cutting-edge technologies of genetics and molecular biology to uncover new mechanisms, signal transduction pathways and their interactions combined with computer aided drug design to identify new drug targets, and to discover and develop new biological and small molecule medicines. The company is committed to serving patients in need by carrying out innovative science including internal research and external collaborations with academics and global biopharmaceutical companies. We are seeking talented individuals who are innovative, ambitious, and great team players to join our vibrant group.
Learn more at www.angitiabio.com
Benefits:
Mondelēz International
Intelliswift Software, Inc.
EY
Ingérop
University of Arkansas System